Xeris Biopharma Holdings, Inc. (XERS) Stock News & Chart

(XERS)

Xeris Biopharma Holdings, Inc.

Stock chart and latest news for Xeris Biopharma Holdings, Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

Xeris Biopharma Holdings, Inc. News

PRO

simplywall.st

Record Profitability, 2026 Growth Outlook and Recorlev Patent Suit Might Change The Case For Investing In Xeris Biopharma Holdings (XERS)

Apr 13, 2026 GuruFocus

Xeris Biopharma: Undervalued Given The Potential Of Its Drug Portfolio (NASDAQ:XERS)

Mar 4, 2026 Stock Titan

Xeris Biopharma (XERS) officer sells 16,667 shares under 10b5-1 plan

Apr 3, 2026 Yahoo Finance

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year

Nov 9, 2025 Investing.com

Brady sells Xeris Biopharma (XERS) shares worth $60,035

Apr 1, 2026 Business Wire

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Apr 3, 2026 Stock Titan

Vanguard (XERS) disaggregates holdings after Jan 12, 2026 realignment; reports 0 shares

Mar 27, 2026 simplywall.st

A Look At Xeris Biopharma Holdings (XERS) Valuation After Its Q4 2025 Earnings Beat

Apr 7, 2026 Yahoo Finance

Xeris Biopharma (XERS) Reports Q4 Earnings: What Key Metrics Have to Say

Mar 2, 2026